View Financial HealthHealing 配当と自社株買い配当金 基準チェック /06Healing配当金を支払った記録がありません。主要情報n/a配当利回りn/aバイバック利回り総株主利回りn/a将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesお知らせ • Feb 15The Healing Company Inc. announced delayed 10-Q filingOn 02/14/2024, The Healing Company Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Nov 18+ 1 more updatethe Healing Company Inc. Announces Resignation of Ameeth Sankaran from BoardThe Healing Company Inc. announced on November 14, 2023, Ameeth Sankaran notified the Company of his decision to resign from the Company’s Board effective immediately. Mr. Sankaran’s resignation did not result from any disagreement with the Company on any matter related to the Company’s operations, policies or practices.お知らせ • Nov 15The Healing Company Inc. announced delayed 10-Q filingOn 11/14/2023, The Healing Company Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Jul 28The Healing Company and Your Super Announces Your Super's Moon Balance Superfood Blend Reduced Period Symptoms in 86% of Clinical Trial ParticipantsThe Healing Company and its portfolio company Your Super announced Your Super's superfood blend, Moon Balance, is now clinically proven to reduce painful periods and associated menstrual symptoms. 80% of clinical trial participants experienced less painful periods after two months of consistent use, while 80% said their premenstrual syndrome (PMS) and menstrual symptoms had improved. With more than 75% of women experiencing PMS, Your Super commissioned Citruslabs, one of the leading clinical research organizations in the United States, to conduct a preliminary study focused on testing Moon Balance's effectiveness in improving common menstrual cycle issues. Topline results from the clinical trial include: Reduced Pain & Dis comfort: Participants reported their menstrual cramps were less severe (by 33%), bloating symptoms improved (by 30%) and they ultimately experienced fewer days of PMS symptoms overall. More Balance: 72% reported fewer mood swings, and 69% shared they felt calmer and less stressed. Improved Sleep Quality: 66% experienced better quality sleep and 59% slept longer. Increased Productivity: 69% canceled fewer plans, missed fewer work hours and were more productive. Retailing at $29.99 for a month's supply, Your Super's Moon Balance superfood blend was mindfully formulated for women with only six nourishing ingredients and no artificial sweeteners, fillers or gums. With more than three thousand five-star customer reviews, Moon Balance is consistently one of Your Super's top rated and highest selling products.お知らせ • Jul 18The Healing Company Inc. (OTCPK:HLCO) completed the acquisition of Northern Pacific Kaviar.The Healing Company Inc. (OTCPK:HLCO) entered into a definitive agreement to acquire Northern Pacific Kaviar on June 29, 2023. As consideration for the transaction, The Healing Company will issue to the shareholders of Northern Pacific Kaviar: (i) 1.6666666 common shares of the Company for each Northern Pacific Kaviar Share, for an aggregate of 16,666,666 Common Shares, and (ii) 1.6666666 warrants to purchase Common Shares for each Northern Pacific Kaviar Warrant, for an aggregate of 16,666,666 Replacement Warrants. The Acquisition is subject to a number of conditions to close, including the approval of the CSE, and it is anticipated that the Acquisition will close in the coming weeks.The Healing Company Inc. (OTCPK:HLCO) completed the acquisition of Northern Pacific Kaviar on July 17, 2023.お知らせ • Jul 09The Healing Company Inc. Announces Board ChangesOn May 26, 2023, the Board of Directors of The Healing Company Inc. elected Ameeth Sankaran to fill the open position on the Board created by the resignation of Poonacha Machaiah from the Board on May 2, 2023. Since January 2017, Mr. Sankaran has served as Chief Executive Officer of Religion of Sports, an Emmy Award winning Media company co-founded by Tom Brady, Michael Strahan and Gotham Chopra, built on the thesis that sports are religion. The company produces content focused on a single narrative of ‘Why Sports Matter’ to explore themes such as, for example, greatness and human potential. Since 2017, Religion of Sports has produced content across media, from short-form video to audio to feature films and has won multiple awards including a Sports Emmy. Ameeth is an Executive Producer of Tom vs. Time, Greatness Code, Stephen vs. the Game, Man in the Arena, and the Crushed podcast among others. Mr. Sankaran also served as an advisor to 2M Companies LLC (“2M”), from 2017 to 2019 and was a Partner at 2M from 2013 to 2016. Prior to that, Ameeth was a Principal at The Boston Consulting Group where he worked from 2005 to 2013. Mr. Sankaran earned a Bachelor of Science degree in Mechanical Engineering from The University of Texas at Austin in 1999 and an MBA in Finance and Management from Columbia Business School in 2005. Ameeth has been engaged for more than 15 years as a strategy consultant and a private equity investor.お知らせ • Jul 07The Healing Company Inc. announced that it has received $7 million in funding from Burman Family Office and other investorsThe Healing Company Inc. announced a private placement and received up to $7 million on July 6, 2023. The transaction included participation from strategic partners including the investment office of the Burman family and esteemed German family office of Stephan and Ingvild Goetz (Munich). Including previously financing, this brings total raised and committed equity funding to up to $17 million, alongside the $150 million credit facility supporting future acquisitions.お知らせ • May 16The Healing Company Inc. announced delayed 10-Q filingOn 05/15/2023, The Healing Company Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Feb 15The Healing Company Inc. announced delayed 10-Q filingOn 02/14/2023, The Healing Company Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Nov 16The Healing Company Inc. announced delayed 10-Q filingOn 11/15/2022, The Healing Company Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Oct 29The Healing Company Inc. announced that it has received $1 million in fundingOn October 28, 2022, The Healing Company Inc. closed the transaction. The transaction included participation from 2 investors.お知らせ • Sep 29The Healing Company Inc. announced delayed annual 10-K filingOn 09/28/2022, The Healing Company Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Jun 15+ 1 more updateThe Healing Company Inc. Announces Executive ChangesOn June 6, 2022, The Healing Company Inc. (the “Company”) received the resignation of Mr. Lee Larson Elmore as Secretary, Treasurer and Chief Financial Officer of the Company. Mr. Elmore did not resign due to any dispute or disagreement with the Company or its practices. On June 6, 2022, the Company received a consent to act as Secretary, Treasurer and Chief Financial Officer of the Company from Amit Kapur. Further, concurrently, the board of directors of the Company (the “Board”) approved Mr. Kapur’s offer letter dated June 2, 2022 (the “Offer Letter”) and appointed Mr. Kapur Secretary, Treasurer and Chief Financial Officer of the Company. Under the terms of the Offer Letter to commence June 6, 2022 (the “Start Date”), Mr. Kapur will be paid an annual base salary of $300,000 subject to review annually for increase, but not decrease, payable semi-monthly in accordance with the standard payroll practices of the Company and subject to all withholdings and deductions as required by law. Further, Mr. Kapur shall have the right to receive an annual bonus as determined by the Board and based on Company results and the achievement of applicable performance goals established by the Board. Additionally, Mr. Kapur shall receive an option to purchase One Million Two Hundred Fifty Thousand (1,250,000) shares of Company common stock in accordance with the terms of the Company’s 2022 Omnibus Equity Incentive Plan and its standard option agreement, once approved by the Board (the “Option”). The Option shall be exercisable at the fair market value of the common stock on the employment Start Date and shall have a term of ten (10) years. The shares subject to the Option shall vest ratably over a four (4) year period commencing on the employment Start Date (“Vesting Start Date”) as follows: 25% upon the 12-month anniversary of the Vesting Start Date, and at a rate of 1/48 of the number of shares initially subject to the Option for each full calendar month thereafter (such that 100% of the Shares shall be vested as of the fourth anniversary of the Vesting Start Date). The employment offer and acceptance is for no fixed term and can be terminated by either party with or without cause, and with or without notice and for any reason or no particular reason. Mr. Kapur will be eligible to participate in the employee benefit plans and programs generally available to the Company’s executives and he will be subject to non-competition and non-solicitation provisions. If Mr. Kapur’s employment with the Company is involuntarily terminated for reasons other than Cause (as defined in the Offer Letter) or a breach by him of the terms and conditions of the Offer Letter (including, but not limited to, a breach of any of the representations contained therein), he shall be entitled to continue to receive his base salary through the three-month anniversary of the effective date of termination if the termination occurs prior to the one-year anniversary of the Start Date, and through the six-month anniversary of the effective date of termination if the termination occurs after the one-year anniversary of the Start Date. Mr. Kapur has more than 20 years of chief financial leadership positions with an array of consumer goods, venture capital, private equity and consulting experience. He is a detailed-oriented, driven, executive with an extremely strong track record of leadership, business development, revenue generation, communication, project management, financial control, operations, IT, capital markets, and other corporate activities. He possesses exceptional analytical skills, with the ability to examine and understand business needs and deliver comprehensive reports for external groups while exceeding rigorous expectations. His academic credentials include a fundamental background in valuation, analytics, and research. His skills include the evaluation of new ventures and investment opportunities. He has a large network of associates which includes CEO/CFO/COOs, high net worth investors, entrepreneurs, and senior management in various industries. Mr. Kapur is joining the Company after spending more than three years (from February 2019) with The Anthos Group, a company with a market cap of $100 million, where he served as Chief Financial Officer and Chief Operating Officer of Farms. During his term at The Anthos Group, he undertook various duties for that company including overseeing and developing policies whereby the company was able to reduce its G&A expenses by 40% and reduce capital expenditures while growing revenues. He also participated in the closing of financings for that company and the structuring and closing of various joint ventures. In 2004, Mr. Kapur founded a real estate private equity fund and he still sits as Chairman of the Board of that company. Mr. Kapur has had varied positions throughout his career, as a senior auditor for a large accounting firm prior to 2004 and from June 2017 to March 2019, he was a member and executive at Toptal, LLC, a company providing an exclusive network of the top freelance software developers, designers, finance experts product managers and project managers where he was assigned various projects over a broad spectrum of companies. Educated at Northwestern? Kellogg School of Management, he has a Master’s of Business Administration with a focus on finance, entrepreneurship and marketing and also holds degrees from the University of Illinois at Chicago (UIC) (Bachelor of Science, Accounting) and the University of Delhi (Bachelor of Science, Business Commerce, Honors). Mr. Kapur also sits on the Board of Directors of Superfyt and is a member of CFOrward and a contributor to Think Deal Training. He is a Board member of Found Chicago Dog Training and Rescue Home, the Vice Chairman of Dreams for Kids, the Founder of Kapur Christmas Drive which annually feeds and clothes hundreds of homeless across Chicago and a Mentor of the Boys and Girls Club.お知らせ • May 17The Healing Company Inc. announced delayed 10-Q filingOn 05/16/2022, The Healing Company Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Mar 29The Healing Company Inc. Appoints Kay Koplovitz to the Board of Directors and as Chairman of the Board Effective April 1, 2022The Healing Company Inc. announced on March 23, 2022, the Board of Directors approved a Board Service Agreement and appointed Kay Koplovitz to the Board of Directors and as Chairman of the Board effective April 1, 2022. Kay Koplovitz is co-Founder & Chairman of Springboard Enterprises. Ms. Koplovitz is the founder and former CEO of USA Networks, the SyFy Channel. Ms. Koplovitz currently serves on the Boards of Athena Consumer Acquisition Corp. SPAC (ACAQ) and private company Veniam.お知らせ • Feb 16The Healing Company Inc. announced delayed 10-Q filingOn 02/15/2022, The Healing Company Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.決済の安定と成長配当データの取得安定した配当: HLCOの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: HLCOの配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場Healing 配当利回り対市場HLCO 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (HLCO)n/a市場下位25% (US)1.4%市場トップ25% (US)4.3%業界平均 (Personal Products)3.4%アナリスト予想 (HLCO) (最長3年)n/a注目すべき配当: HLCOは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: HLCOは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: HLCOの 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: HLCOが配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YUS 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/04/01 15:39終値2026/01/02 00:00収益2023/09/30年間収益2023/06/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋The Healing Company Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Feb 15The Healing Company Inc. announced delayed 10-Q filingOn 02/14/2024, The Healing Company Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Nov 18+ 1 more updatethe Healing Company Inc. Announces Resignation of Ameeth Sankaran from BoardThe Healing Company Inc. announced on November 14, 2023, Ameeth Sankaran notified the Company of his decision to resign from the Company’s Board effective immediately. Mr. Sankaran’s resignation did not result from any disagreement with the Company on any matter related to the Company’s operations, policies or practices.
お知らせ • Nov 15The Healing Company Inc. announced delayed 10-Q filingOn 11/14/2023, The Healing Company Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Jul 28The Healing Company and Your Super Announces Your Super's Moon Balance Superfood Blend Reduced Period Symptoms in 86% of Clinical Trial ParticipantsThe Healing Company and its portfolio company Your Super announced Your Super's superfood blend, Moon Balance, is now clinically proven to reduce painful periods and associated menstrual symptoms. 80% of clinical trial participants experienced less painful periods after two months of consistent use, while 80% said their premenstrual syndrome (PMS) and menstrual symptoms had improved. With more than 75% of women experiencing PMS, Your Super commissioned Citruslabs, one of the leading clinical research organizations in the United States, to conduct a preliminary study focused on testing Moon Balance's effectiveness in improving common menstrual cycle issues. Topline results from the clinical trial include: Reduced Pain & Dis comfort: Participants reported their menstrual cramps were less severe (by 33%), bloating symptoms improved (by 30%) and they ultimately experienced fewer days of PMS symptoms overall. More Balance: 72% reported fewer mood swings, and 69% shared they felt calmer and less stressed. Improved Sleep Quality: 66% experienced better quality sleep and 59% slept longer. Increased Productivity: 69% canceled fewer plans, missed fewer work hours and were more productive. Retailing at $29.99 for a month's supply, Your Super's Moon Balance superfood blend was mindfully formulated for women with only six nourishing ingredients and no artificial sweeteners, fillers or gums. With more than three thousand five-star customer reviews, Moon Balance is consistently one of Your Super's top rated and highest selling products.
お知らせ • Jul 18The Healing Company Inc. (OTCPK:HLCO) completed the acquisition of Northern Pacific Kaviar.The Healing Company Inc. (OTCPK:HLCO) entered into a definitive agreement to acquire Northern Pacific Kaviar on June 29, 2023. As consideration for the transaction, The Healing Company will issue to the shareholders of Northern Pacific Kaviar: (i) 1.6666666 common shares of the Company for each Northern Pacific Kaviar Share, for an aggregate of 16,666,666 Common Shares, and (ii) 1.6666666 warrants to purchase Common Shares for each Northern Pacific Kaviar Warrant, for an aggregate of 16,666,666 Replacement Warrants. The Acquisition is subject to a number of conditions to close, including the approval of the CSE, and it is anticipated that the Acquisition will close in the coming weeks.The Healing Company Inc. (OTCPK:HLCO) completed the acquisition of Northern Pacific Kaviar on July 17, 2023.
お知らせ • Jul 09The Healing Company Inc. Announces Board ChangesOn May 26, 2023, the Board of Directors of The Healing Company Inc. elected Ameeth Sankaran to fill the open position on the Board created by the resignation of Poonacha Machaiah from the Board on May 2, 2023. Since January 2017, Mr. Sankaran has served as Chief Executive Officer of Religion of Sports, an Emmy Award winning Media company co-founded by Tom Brady, Michael Strahan and Gotham Chopra, built on the thesis that sports are religion. The company produces content focused on a single narrative of ‘Why Sports Matter’ to explore themes such as, for example, greatness and human potential. Since 2017, Religion of Sports has produced content across media, from short-form video to audio to feature films and has won multiple awards including a Sports Emmy. Ameeth is an Executive Producer of Tom vs. Time, Greatness Code, Stephen vs. the Game, Man in the Arena, and the Crushed podcast among others. Mr. Sankaran also served as an advisor to 2M Companies LLC (“2M”), from 2017 to 2019 and was a Partner at 2M from 2013 to 2016. Prior to that, Ameeth was a Principal at The Boston Consulting Group where he worked from 2005 to 2013. Mr. Sankaran earned a Bachelor of Science degree in Mechanical Engineering from The University of Texas at Austin in 1999 and an MBA in Finance and Management from Columbia Business School in 2005. Ameeth has been engaged for more than 15 years as a strategy consultant and a private equity investor.
お知らせ • Jul 07The Healing Company Inc. announced that it has received $7 million in funding from Burman Family Office and other investorsThe Healing Company Inc. announced a private placement and received up to $7 million on July 6, 2023. The transaction included participation from strategic partners including the investment office of the Burman family and esteemed German family office of Stephan and Ingvild Goetz (Munich). Including previously financing, this brings total raised and committed equity funding to up to $17 million, alongside the $150 million credit facility supporting future acquisitions.
お知らせ • May 16The Healing Company Inc. announced delayed 10-Q filingOn 05/15/2023, The Healing Company Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Feb 15The Healing Company Inc. announced delayed 10-Q filingOn 02/14/2023, The Healing Company Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Nov 16The Healing Company Inc. announced delayed 10-Q filingOn 11/15/2022, The Healing Company Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Oct 29The Healing Company Inc. announced that it has received $1 million in fundingOn October 28, 2022, The Healing Company Inc. closed the transaction. The transaction included participation from 2 investors.
お知らせ • Sep 29The Healing Company Inc. announced delayed annual 10-K filingOn 09/28/2022, The Healing Company Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Jun 15+ 1 more updateThe Healing Company Inc. Announces Executive ChangesOn June 6, 2022, The Healing Company Inc. (the “Company”) received the resignation of Mr. Lee Larson Elmore as Secretary, Treasurer and Chief Financial Officer of the Company. Mr. Elmore did not resign due to any dispute or disagreement with the Company or its practices. On June 6, 2022, the Company received a consent to act as Secretary, Treasurer and Chief Financial Officer of the Company from Amit Kapur. Further, concurrently, the board of directors of the Company (the “Board”) approved Mr. Kapur’s offer letter dated June 2, 2022 (the “Offer Letter”) and appointed Mr. Kapur Secretary, Treasurer and Chief Financial Officer of the Company. Under the terms of the Offer Letter to commence June 6, 2022 (the “Start Date”), Mr. Kapur will be paid an annual base salary of $300,000 subject to review annually for increase, but not decrease, payable semi-monthly in accordance with the standard payroll practices of the Company and subject to all withholdings and deductions as required by law. Further, Mr. Kapur shall have the right to receive an annual bonus as determined by the Board and based on Company results and the achievement of applicable performance goals established by the Board. Additionally, Mr. Kapur shall receive an option to purchase One Million Two Hundred Fifty Thousand (1,250,000) shares of Company common stock in accordance with the terms of the Company’s 2022 Omnibus Equity Incentive Plan and its standard option agreement, once approved by the Board (the “Option”). The Option shall be exercisable at the fair market value of the common stock on the employment Start Date and shall have a term of ten (10) years. The shares subject to the Option shall vest ratably over a four (4) year period commencing on the employment Start Date (“Vesting Start Date”) as follows: 25% upon the 12-month anniversary of the Vesting Start Date, and at a rate of 1/48 of the number of shares initially subject to the Option for each full calendar month thereafter (such that 100% of the Shares shall be vested as of the fourth anniversary of the Vesting Start Date). The employment offer and acceptance is for no fixed term and can be terminated by either party with or without cause, and with or without notice and for any reason or no particular reason. Mr. Kapur will be eligible to participate in the employee benefit plans and programs generally available to the Company’s executives and he will be subject to non-competition and non-solicitation provisions. If Mr. Kapur’s employment with the Company is involuntarily terminated for reasons other than Cause (as defined in the Offer Letter) or a breach by him of the terms and conditions of the Offer Letter (including, but not limited to, a breach of any of the representations contained therein), he shall be entitled to continue to receive his base salary through the three-month anniversary of the effective date of termination if the termination occurs prior to the one-year anniversary of the Start Date, and through the six-month anniversary of the effective date of termination if the termination occurs after the one-year anniversary of the Start Date. Mr. Kapur has more than 20 years of chief financial leadership positions with an array of consumer goods, venture capital, private equity and consulting experience. He is a detailed-oriented, driven, executive with an extremely strong track record of leadership, business development, revenue generation, communication, project management, financial control, operations, IT, capital markets, and other corporate activities. He possesses exceptional analytical skills, with the ability to examine and understand business needs and deliver comprehensive reports for external groups while exceeding rigorous expectations. His academic credentials include a fundamental background in valuation, analytics, and research. His skills include the evaluation of new ventures and investment opportunities. He has a large network of associates which includes CEO/CFO/COOs, high net worth investors, entrepreneurs, and senior management in various industries. Mr. Kapur is joining the Company after spending more than three years (from February 2019) with The Anthos Group, a company with a market cap of $100 million, where he served as Chief Financial Officer and Chief Operating Officer of Farms. During his term at The Anthos Group, he undertook various duties for that company including overseeing and developing policies whereby the company was able to reduce its G&A expenses by 40% and reduce capital expenditures while growing revenues. He also participated in the closing of financings for that company and the structuring and closing of various joint ventures. In 2004, Mr. Kapur founded a real estate private equity fund and he still sits as Chairman of the Board of that company. Mr. Kapur has had varied positions throughout his career, as a senior auditor for a large accounting firm prior to 2004 and from June 2017 to March 2019, he was a member and executive at Toptal, LLC, a company providing an exclusive network of the top freelance software developers, designers, finance experts product managers and project managers where he was assigned various projects over a broad spectrum of companies. Educated at Northwestern? Kellogg School of Management, he has a Master’s of Business Administration with a focus on finance, entrepreneurship and marketing and also holds degrees from the University of Illinois at Chicago (UIC) (Bachelor of Science, Accounting) and the University of Delhi (Bachelor of Science, Business Commerce, Honors). Mr. Kapur also sits on the Board of Directors of Superfyt and is a member of CFOrward and a contributor to Think Deal Training. He is a Board member of Found Chicago Dog Training and Rescue Home, the Vice Chairman of Dreams for Kids, the Founder of Kapur Christmas Drive which annually feeds and clothes hundreds of homeless across Chicago and a Mentor of the Boys and Girls Club.
お知らせ • May 17The Healing Company Inc. announced delayed 10-Q filingOn 05/16/2022, The Healing Company Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Mar 29The Healing Company Inc. Appoints Kay Koplovitz to the Board of Directors and as Chairman of the Board Effective April 1, 2022The Healing Company Inc. announced on March 23, 2022, the Board of Directors approved a Board Service Agreement and appointed Kay Koplovitz to the Board of Directors and as Chairman of the Board effective April 1, 2022. Kay Koplovitz is co-Founder & Chairman of Springboard Enterprises. Ms. Koplovitz is the founder and former CEO of USA Networks, the SyFy Channel. Ms. Koplovitz currently serves on the Boards of Athena Consumer Acquisition Corp. SPAC (ACAQ) and private company Veniam.
お知らせ • Feb 16The Healing Company Inc. announced delayed 10-Q filingOn 02/15/2022, The Healing Company Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.